BioNexus Gene Lab (BGLC) Restructuring Costs (2020 - 2025)

BioNexus Gene Lab's Restructuring Costs history runs 6 years deep, the most recent figure standing at $181095.0 for Q4 2025.

• In Q4 2025, Restructuring Costs rose 9.14% year-over-year to $181095.0; the TTM figure through Dec 2025 stood at $1.5 million (down 16.23% YoY), while the FY2025 annual figure was $1.5 million, down 16.23% from the prior year.
• Restructuring Costs came in at $181095.0 for Q4 2025 at BioNexus Gene Lab, down from $445691.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $3.1 million in Q3 2023 to a low of -$2.0 million in Q4 2023.
• A 5-year average of $440918.4 and a median of $450231.0 in 2022 frame the typical range for Restructuring Costs.
• Across the five-year window, Restructuring Costs jumped 2894.45% in 2021 and tumbled 506.52% in 2023, its largest moves.
• BioNexus Gene Lab's Restructuring Costs stood at $1.2 million in 2021, then plunged by 58.01% to $487858.0 in 2022, then sank by 506.52% to -$2.0 million in 2023, then surged by 108.37% to $165932.0 in 2024, then rose by 9.14% to $181095.0 in 2025.
• According to Business Quant data, Restructuring Costs over the past three periods registered $181095.0, $445691.0, and $516790.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison